BioSpace News Archive

Press Releases

European Commission approves TREMFYA® (guselkumab), the first dual-acting IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease

May 7, 2025
·
18 min read
Press Releases

Oculis to Present at Upcoming May 2025 Investor Conferences

May 7, 2025
·
2 min read
Press Releases

Isarna Therapeutics Presents Positive Phase 2 BETTER Trial Final Results at ARVO 2025

May 7, 2025
·
2 min read
Press Releases

AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic

May 7, 2025
·
2 min read
Press Releases

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

May 7, 2025
·
6 min read
Press Releases

BeiGene Announces First Quarter 2025 Financial Results and Business Updates

May 7, 2025
·
20 min read
Press Releases

The Caris Precision Oncology Alliance Welcomes LSU LCMC Health Cancer Center

May 7, 2025
·
4 min read
Press Releases

Merck to Participate in the Bank of America 2025 Global Healthcare Conference

May 7, 2025
·
3 min read
Press Releases

Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance

May 7, 2025
·
30 min read
Press Releases

Genprex Signs Sponsored Research Agreement with the University of Pittsburgh to Study Diabetes Gene Therapy in Type 1 and Type 2 Diabetes

May 7, 2025
·
8 min read